Callum Metcalfe O'Shea advises how to manage a middle-aged male patient with hypertension who is refusing to take his ...

Ace Therapeutics announced custom animal models of hypertension, designed to help understand hypertension pathogenesis ...

The advanced procedure targets kidney nerves contributing to high blood pressure, offering new hope for patients unresponsive ...

Feb 25 (Reuters) - GSK has agreed to pay $950 million in cash for Canadian biotech 35Pharma, it said on Wednesday, marking ...

LONDON — Building up its base of medicines for lung diseases, GSK said Wednesday it was buying the privately held firm 35Pharma for $950 million in cash. The centerpiece of the deal is an experimental ...

A low-dose, single-pill combination proved to be as effective as — and in some cases, superior to — standard-dose monotherapy ...

35Pharma's lead development programme is HS235, an activin receptor-targeting fusion protein that has completed phase 1 ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

Most people overlook it, but research links this supplement to a range of health benefits.

A MEDICINE for hypertension has been delisted by the Food and Drug Administration (FDA) from the updated list of Value-Added ...

GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...

The British pharma giant is paying cash for a Montreal-Boston biotech developing a drug for a serious lung condition.